American Financial Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.

Press releases published on November 2, 2026

Nov. 2, 2026

Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data

Indeterminate GlobeNewswire

Nov. 2, 2026

Theriva™ Biologics Announces Sale of SYN-004 (ribaxamase) and Related Antibiotic-Degrading Enzyme Portfolio to Biossil Labs Inc.

Indeterminate GlobeNewswire

Nov. 2, 2026

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Tuesday, November 10, 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

Humacyte To Announce 2026 Third Quarter Financial Results and Provide Business Update on November 10, 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation

Indeterminate GlobeNewswire

Nov. 2, 2026

NeOnc Technologies to Present Data from Its NEO100 and NEO212 Programs at the 31st Annual Meeting of the Society for Neuro-Oncology

Indeterminate GlobeNewswire

Nov. 2, 2026

Theriva™ Biologics anuncia la venta de SYN-004 (ribaxamasa) y la cartera de enzimas degradadoras de antibióticos asociada a Biossil Labs Inc.

Indeterminate GlobeNewswire

Nov. 2, 2026

CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer

Indeterminate GlobeNewswire

Nov. 2, 2026

General Fusion to Host Third Quarter 2026 Results Conference Call

Indeterminate GlobeNewswire

Nov. 2, 2026

AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry

Indeterminate GlobeNewswire

Nov. 2, 2026

DeFi Development Corp. Surpasses 2.6 Million SOL as CHAD’s 14% Annualized Dividend Rate Takes Effect

Indeterminate GlobeNewswire

Nov. 2, 2026

The Office Gurus Announces Acquisition of Select VoiceCom, Expanding Global Delivery Capabilities in the Philippines

Indeterminate GlobeNewswire

Nov. 2, 2026

Catheter Precision Announces New FDA 510(k) Clearance for its VIVO System, Enabling Use in a Broader Patient Population

Indeterminate GlobeNewswire

Nov. 2, 2026

Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease Study

Indeterminate GlobeNewswire

Nov. 2, 2026

Baird Medical and China Resources Pharmaceutical Commercial Group Medical Devices Sign Strategic Distribution Agreement to Expand Access to Microwave Ablation in China

Indeterminate GlobeNewswire

Nov. 2, 2026

UroGen Announces First Patient Dosed in Phase 1 Trial of UGN-501, an Investigational Next-Generation Oncolytic Virus for Non-Muscle Invasive Bladder Cancer

Indeterminate GlobeNewswire

Nov. 2, 2026

Callan JMB Announces Arrival of Rapid Dose Therapeutics’ QuickStrip™, Resulting in $15 Million in Projected Revenue Over the Next 18 months

Indeterminate GlobeNewswire

Nov. 2, 2026

Actuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets

Indeterminate GlobeNewswire

Nov. 2, 2026

Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 2, 2026

Chemomab Therapeutics and Scipher Medicine Announce SEC Registration Statement on Form S-4 Is Effective

Indeterminate GlobeNewswire